Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bladder Cancer
  Free Subscription

20.04.2026

1 Adv Ther
2 Am J Clin Pathol
1 Anal Chem
3 Ann Surg Oncol
1 Appl Biochem Biotechnol
1 Arkh Patol
1 Biochim Biophys Acta Mol Cell Res
1 Biol Direct
1 Biomark Res
1 Bladder Cancer
1 Br J Cancer
1 Cancer Cell
1 Cancer Res Commun
1 Cancers (Basel)
2 Cell Death Dis
1 Cell Death Discov
1 Clin Genitourin Cancer
1 Clin Lab
1 Curr Urol Rep
1 Ecotoxicol Environ Saf
1 Front Oncol
1 Genes Genomics
1 IEEE J Biomed Health Inform
1 Immunotherapy
1 Int J Mol Sci
1 Int J Nanomedicine
1 Int J Urol
1 iScience
1 J Cell Mol Med
1 J Clin Oncol
1 J Ethnopharmacol
1 J Nanobiotechnology
2 J Transl Med
1 JAMA Netw Open
1 Medicine (Baltimore)
1 Mod Pathol
1 Mol Biol Rep
1 Nat Rev Urol
1 Onco Targets Ther
1 Oncol Lett
1 Palliat Support Care
1 Patient Prefer Adherence
1 PLoS One
2 Scand J Urol
1 Sci Adv
3 Sci Rep
2 Transl Androl Urol
1 Transl Cancer Res
1 Transl Oncol
2 Urol Oncol
1 Urologia
1 World J Surg Oncol
1 Zhonghua Yi Xue Za Zhi


    Adv Ther

  1. KANESVARAN R, Giannatempo P, Filicevas A
    Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced Bladder Cancer-A Podcast.
    Adv Ther. 2026 Apr 15. doi: 10.1007/s12325-026-03535.
    >> Share


    Am J Clin Pathol

  2. MOLNAR A, Montoya-Cerrillo D, Montgomery EA, Kryvenko ON, et al
    The ancillary role of D2-40 in demonstration of muscularis propria invasion vs desmoplastic reaction in invasive urothelial carcinoma of the bladder.
    Am J Clin Pathol. 2026;165:aqag025.
    >> Share

  3. GUPTA S, Kosari F, Thapa P, Murphy SJ, et al
    Sarcomatoid urothelial carcinoma with constitutive PD-L1 overexpression.
    Am J Clin Pathol. 2026;165:aqag023.
    >> Share


    Anal Chem

  4. BAO Q, Yoshioka T, Sato S, Goto S, et al
    Correlation-Based Morphometric Analysis Reveals Structural Remodeling of Platelet-Bound Circulating Tumor Cells in Urothelial Carcinoma.
    Anal Chem. 2026;98:10668-10675.
    >> Share


    Ann Surg Oncol

  5. YANG Y, Wu Y, Yang K, Song G, et al
    Preliminary Experience of Transurethral Thulium Laser En Bloc Resection of Paraganglioma of the Urinary Bladder.
    Ann Surg Oncol. 2026;33:4806-4811.
    >> Share

  6. LI H, Mou Y, Liu Z, Yu C, et al
    Robotic Ureteroileal Bypass Repair for Post-Cystectomy Bricker Ureteroenteric Anastomotic Strictures: Stepwise Approach and Clinic Outcomes.
    Ann Surg Oncol. 2026;33:4850-4857.
    >> Share

  7. LI C, Cheng C, Li S, Wang D, et al
    Integration of Node-RADS and Habitat Radiomics for Predicting Occult Nodal Metastasis in Bladder Cancer.
    Ann Surg Oncol. 2026 Apr 12. doi: 10.1245/s10434-026-19624.
    >> Share


    Appl Biochem Biotechnol

  8. SUN X, Qi Q, Ding X, Wang X, et al
    The Tumor-Promoting Role of ADM in Bladder Cancer and its Mediated Mechanisms of Cell Death via PKR and STAT1.
    Appl Biochem Biotechnol. 2026 Apr 14. doi: 10.1007/s12010-026-05691.
    >> Share


    Arkh Patol

  9. SYCHEVA IN, Oleynikova NA
    [The features of cancer-associated fibroblasts as components of tumor stroma in bladder cancer].
    Arkh Patol. 2026;88:87-93.
    >> Share


    Biochim Biophys Acta Mol Cell Res

  10. YAO K, Wang L, Wang J, Liu J, et al
    FTO-mediated m6A demethylation inhibits bladder cancer progression via decreasing EMG1 and reducing ribosome biosynthesis.
    Biochim Biophys Acta Mol Cell Res. 2026;1873:120147.
    >> Share


    Biol Direct

  11. WANG Y, Gong S, Shen J, Liu G, et al
    Integrative analysis of myeloid cell signatures identifies a prognostic risk model and potential mechanisms in bladder cancer.
    Biol Direct. 2026 Apr 16. doi: 10.1186/s13062-026-00785.
    >> Share


    Biomark Res

  12. ANDRZEJCZAK A, Krajewski W, Jaskula E, Chorbinska J, et al
    Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.
    Biomark Res. 2026;14:44.
    >> Share


    Bladder Cancer

  13. MAI M, Tran V, Zhu A, Appiah D, et al
    Patterns of care and associated social determinants of health in the definitive treatment of localized muscle-invasive bladder cancer patients.
    Bladder Cancer. 2026;12:23523735261438727.
    >> Share


    Br J Cancer

  14. TEKE K, Ozer C, Yaprak Bayrak B, Reyhancan IA, et al
    Boron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach.
    Br J Cancer. 2026 Apr 17. doi: 10.1038/s41416-026-03418.
    >> Share


    Cancer Cell

  15. MAHADEVAN KK, Kalluri R
    Tumor-restraining fibroblasts emerge after chemotherapy specifically in responders.
    Cancer Cell. 2026;44:708-709.
    >> Share


    Cancer Res Commun

  16. ANDERSEN L, Lindskrog SV, Nordentoft I, Frydendahl A, et al
    Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes.
    Cancer Res Commun. 2026;6:811-820.
    >> Share


    Cancers (Basel)

  17. CANCERS EDITORIAL OFFICE
    Expression of Concern: Juengel et al. Mechanisms Behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro. Cancers 2019, 11, 777.
    Cancers (Basel). 2026;18:1077.
    >> Share


    Cell Death Dis

  18. FAN X, Li Z, Gao Q, Huang P, et al
    TRIM28 orchestrates SUMO-ubiquitin crosstalk to stabilize PPARG and drive bladder cancer progression.
    Cell Death Dis. 2026 Apr 13. doi: 10.1038/s41419-026-08745.
    >> Share

  19. HUI K, Gao Y, Huang J, Xu S, et al
    Correction: RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Cell Death Dis. 2026;17:393.
    >> Share


    Cell Death Discov

  20. NIU S, Yang P, Yao Y, Tang X, et al
    NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancer.
    Cell Death Discov. 2026 Apr 14. doi: 10.1038/s41420-026-03091.
    >> Share


    Clin Genitourin Cancer

  21. MUSAEV A, Akpinar C, Ulgen TK, Erkmen S, et al
    Impact of Different Surveillance Intervals on Recurrence and Progression in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2026;24:102543.
    >> Share


    Clin Lab

  22. CHA JH, Kim KJ, Yun SG, Nam MH, et al
    Diagnostic Aspects of a Bacillus Calmette-Guerin (BCG) Infection Following Intravesical Treatment for Bladder Cancer.
    Clin Lab. 2026;72.
    >> Share


    Curr Urol Rep

  23. ANGULO-LOZANO JC, Calvillo-Ramirez A, Noyola-Perez A, Cojuc-Konigsberg G, et al
    Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.
    Curr Urol Rep. 2026;27:21.
    >> Share


    Ecotoxicol Environ Saf

  24. WANG J, Lu M, Qi N, Zhang M, et al
    Integrated machine learning and experimental validation reveal S6K2 as a key target of 6PPD-quinone in bladder cancer.
    Ecotoxicol Environ Saf. 2026;316:120085.
    >> Share


    Front Oncol

  25. BAJDAK-RUSINEK K, Jankowska K, Sundararajan V, Sieron L, et al
    ESRP2 constrains EMT plasticity associated with ZEB1 expression in bladder cancer.
    Front Oncol. 2026;16:1764850.
    >> Share


    Genes Genomics

  26. PARK C, Hwangbo H, Hong SH, Jeong HJ, et al
    5-Aminoimidazole-4-carboxamide riboside, an AMPK activator, enhances TRAIL-mediated apoptosis in human bladder cancer cells in a p38 MAPK-dependent manner.
    Genes Genomics. 2026 Apr 15. doi: 10.1007/s13258-026-01764.
    >> Share


    IEEE J Biomed Health Inform

  27. SONG Y, Yang Y, Qin J, Zhang Q, et al
    Transformer-Enhanced Joint Information Extraction Framework for Bladder Cancer Medical Dialogue Analysis.
    IEEE J Biomed Health Inform. 2026;PP.
    >> Share


    Immunotherapy

  28. MENEGAT ALRS, Menegat BLRS, Braz LDG, Piccoli MVF, et al
    Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial carcinoma: a systematic review and meta-analysis.
    Immunotherapy. 2026;18:139-155.
    >> Share


    Int J Mol Sci

  29. LIPKA U, Orywal K, Gudowska-Sawczuk M
    Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer: Diagnostic and Prognostic Perspectives: Narrative Review.
    Int J Mol Sci. 2026;27:3218.
    >> Share


    Int J Nanomedicine

  30. LIU Y, Chen Y, Ye S, Hu J, et al
    Microwave-Responsive MnFe-Based Molybdenum Disulfide Nanoflowers for Enhanced Thermal-Dynamic-Chemo Synergistic Therapy in Bladder Cancer.
    Int J Nanomedicine. 2026;21:587614.
    >> Share


    Int J Urol

  31. MUTA R, Fukushima H, Tanaka H, Numao N, et al
    Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study).
    Int J Urol. 2026;33:e70459.
    >> Share


    iScience

  32. TONG H, Li T, Zhu J, Dou Q, et al
    RBM11 drives malignant progression of bladder cancer by regulating GNPDA1-PKM2 axis.
    iScience. 2026;29:115402.
    >> Share


    J Cell Mol Med

  33. DENG H, Mi Y, Zhang L, Tan Y, et al
    ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer.
    J Cell Mol Med. 2026;30:e71147.
    >> Share


    J Clin Oncol


  34. Body Size and Bladder Cancer Risk: A Pooled Analysis of Prospective Studies From the National Cancer Institute Cohort Consortium.
    J Clin Oncol. 2026 Apr 17:JCO2502155. doi: 10.1200/JCO-25-02155.
    >> Share


    J Ethnopharmacol

  35. HAN X, Dong S, Wang Y, Fang X, et al
    Grape seed proanthocyanidin extract suppresses bladder cancer by dual blockade of IMPDH1/2-mediated purine and pyrimidine nucleotide biosynthesis.
    J Ethnopharmacol. 2026 Apr 8:121663. doi: 10.1016/j.jep.2026.121663.
    >> Share


    J Nanobiotechnology

  36. WEN J, Zhou B, Zhang H, Tang Y, et al
    Unlocking caspase-8 enables Pt(IV) to trigger robust caspase-3/GSDME-mediated pyroptosis via drug co-delivery in chemoresistant bladder cancer.
    J Nanobiotechnology. 2026 Apr 12. doi: 10.1186/s12951-026-04449.
    >> Share


    J Transl Med

  37. CHEN Q, Chen T, Gan L, Lu Y, et al
    Mitophagy in bladder cancer: a double-edged sword in tumor progression and therapy.
    J Transl Med. 2026;24:523.
    >> Share

  38. HAN Y, Zheng Z, Li X, Fan W, et al
    Letter to the editor: TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
    J Transl Med. 2026;24:489.
    >> Share


    JAMA Netw Open

  39. GIATSOGLOU M, Chatzistavrou D, Sopczynski JM, Feng G, et al
    Clinical Outcomes in Bacillus Calmette-Guerin-Exposed Non-Muscle-Invasive Bladder Cancer.
    JAMA Netw Open. 2026;9:e267470.
    >> Share


    Medicine (Baltimore)

  40. HAO Y, Niu L, Shih YA, Gao P, et al
    A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence in patients with non-muscle-invasive bladder cancer.
    Medicine (Baltimore). 2026;105:e48370.
    >> Share


    Mod Pathol

  41. LI H, Argani P, Gross JM, Zhu J, et al
    Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory Myofibroblastic Tumor.
    Mod Pathol. 2026;39:100980.
    >> Share


    Mol Biol Rep

  42. MENBARI OSKOUIE I, Khatami F, Mesbah G, Baghdadabad LZ, et al
    Melatonin enhances the antitumor and immunomodulatory effects of Bacillus Calmette-Guerin immunotherapy in a murine bladder cancer model.
    Mol Biol Rep. 2026;53:600.
    >> Share


    Nat Rev Urol

  43. ESTEBAN-VILLARRUBIA J, de Velasco G
    Targeting metastatic bladder cancer when money is an issue.
    Nat Rev Urol. 2026 Apr 13. doi: 10.1038/s41585-026-01142.
    >> Share


    Onco Targets Ther


  44. Downregulation of Long Noncoding RNA TUG1 Inhibits Proliferation and Induces Apoptosis Through the TUG1/miR-142/ZEB2 Axis in Bladder Cancer Cells [Retraction].
    Onco Targets Ther. 2026;19:614701.
    >> Share


    Oncol Lett

  45. ZHU YP, Bian XJ, Ye DW, Yao XD, et al
    [Expression of Concern] Pseudomonas aeruginosa-mannose-sensitive hema-gglutinin inhibits proliferation and induces apoptosis in a caspase-dependent manner in human bladder cancer cell lines.
    Oncol Lett. 2026;31:208.
    >> Share


    Palliat Support Care

  46. PUSTAKE M, Railkar A, Ganiyani MA, Khosla AA, et al
    Trends in preferred place of death among patients with bladder cancer in the United States, 2000 to 2020.
    Palliat Support Care. 2026;24:e108.
    >> Share


    Patient Prefer Adherence

  47. ZHANG M, Zhou Y
    Bidirectional Longitudinal Associations Among Health-Related Quality of Life, Emotional Expressivity, and Readiness to Return to Work in Patients with Non-Muscle-Invasive Bladder Cancer Receiving Intravesical Therapy: A Three-Wave Cohort Study.
    Patient Prefer Adherence. 2026;20:594081.
    >> Share


    PLoS One

  48. GUO D, Li X, Xu X, Chen X, et al
    The Physicochemical Synergy Effect of Nanosecond Pulsed Electric Fields (nsPEF) and cisplatin on reversing chemoresistance of bladder cancer.
    PLoS One. 2026;21:e0346699.
    >> Share


    Scand J Urol

  49. BJORNSSON O, Geirsson G, Leifsson AS, Nikulasson SThorn, et al
    Early recurrence after primary TURBT for non-muscle-invasive bladder cancer in Iceland: the critical role of surgical quality.
    Scand J Urol. 2026;61:131-137.
    >> Share

  50. MESINOVIC D, Bobjer J, Hagberg O, Aljabery F, et al
    Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer.
    Scand J Urol. 2026;61:127-130.
    >> Share


    Sci Adv

  51. ZHAO C, Hou D, Wang K, Chen J, et al
    Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer.
    Sci Adv. 2026;12:eaeb9764.
    >> Share


    Sci Rep

  52. WANG J, Liu H, Li K, Xie Z, et al
    Therapeutic potential of asparagus polysaccharide in bladder cancer treatment via modulation of PI3K/AKT/mTOR signaling.
    Sci Rep. 2026 Apr 15. doi: 10.1038/s41598-026-47595.
    >> Share

  53. WANG L, Zhang J, Liu Y, Sun Y, et al
    Machine learning prediction of postoperative recurrence in bladder cancer using clinical and laboratory indicators.
    Sci Rep. 2026 Apr 15. doi: 10.1038/s41598-026-48493.
    >> Share

  54. ZHA J, Guo X, Liao W, Wu P, et al
    Inhibition of TRPC6 channel suppresses bladder cancer proliferation by disrupting store-operated calcium entry.
    Sci Rep. 2026 Apr 14. doi: 10.1038/s41598-026-45219.
    >> Share


    Transl Androl Urol

  55. OSKARSSON E, Johansson M, Liden O, Alamdari F, et al
    Comorbidity alterations between time for diagnosis and radical cystectomy in patients with muscle invasive bladder cancer undergoing neoadjuvant chemotherapy.
    Transl Androl Urol. 2026;15:77.
    >> Share

  56. LIU Q, Zhou P, Tian D
    Identification of RNA processing-related gene-based bladder cancer subtypes for prognosis and immune landscape assessment.
    Transl Androl Urol. 2026;15:74.
    >> Share


    Transl Cancer Res

  57. MENG H, Wang X, Liu P, Liu Q, et al
    Development and feasibility assessment of an automated, synthetic CT-guided plan selection system for bladder cancer adaptive radiotherapy: a retrospective pilot study.
    Transl Cancer Res. 2026;15:194.
    >> Share


    Transl Oncol

  58. ZHU L, Liu Y, Lan J, Cai E, et al
    Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients.
    Transl Oncol. 2026;68:102770.
    >> Share


    Urol Oncol

  59. UYSAL D, Reible B, Wildner L, Steidler A, et al
    Concordance and prognostic value of antibody drug conjugate and checkpoint inhibition targets in matched bladder cancer specimens from transurethral resection of the bladder, radical cystectomy and lymphadenectomy.
    Urol Oncol. 2026 Apr 14:111095. doi: 10.1016/j.urolonc.2026.111095.
    >> Share

  60. SCILIPOTI P, Zaurito P, Longoni M, Occhi A, et al
    The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin.
    Urol Oncol. 2026 Apr 11:111085. doi: 10.1016/j.urolonc.2026.111085.
    >> Share


    Urologia

  61. PACINI P, Orecchia L, Asimakopoulos AD, Manfredi M, et al
    The role of Bladder EpiCheck((R)) test in predicting residual tumor after transurethral resection of bladder cancer: Results from a pilot study.
    Urologia. 2026 Apr 16:3915603261440213. doi: 10.1177/03915603261440213.
    >> Share


    World J Surg Oncol

  62. PENG S, Liu Y, Huang P, Liu Q, et al
    MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic response.
    World J Surg Oncol. 2026 Apr 14. doi: 10.1186/s12957-026-04346.
    >> Share


    Zhonghua Yi Xue Za Zhi

  63. LIANG S, Qie YK, Jia KP, Bai YD, et al
    [Efficacy and safety of transvaginal assisted total intracavitary orthotopic neobladder surgery for female urothelial carcinoma of the bladder].
    Zhonghua Yi Xue Za Zhi. 2026;106:1484-1488.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016